What is CorMedix's nontaxable or nondeductible items?

CorMedix (CRMD) reported nontaxable or nondeductible items of 0.4% in Q4 2025.

What does nontaxable or nondeductible items mean?

Measures the impact of non-deductible expenses on the company's effective tax rate as a percentage. It highlights how specific regulatory limitations on expense deductions influence the overall tax burden relative to statutory rates.

CorMedix CRMD Nontaxable or nondeductible items

Nontaxable or nondeductible items at other companies

NWN

Northwest NaturalNWN

1.1%+0.4pp

ARD

Ardent Health PartnersARDT

0.3%-0.1pp

Virtu FinancialVIRT

0%—

BlackbaudBLKB

0%0.0pp

PopularBPOP

-19.4%—

Skyline ChampionSKY

0.5%—

Other financials

Income statement

See full

Revenue$127.4M+226%

Gross profit$115.4M+207%

Operating income$63.7M+216%

Net income$38.6M+87.0%

EPS (diluted)$0.43+43.3%

Balance sheet

See full

Cash & equivalents$179.1M+170%

Total debt$4.3M+729%

Total equity$437.0M+280%

Total assets$815.6M+445%

Cash flow

See full

Operating cash flow$42.4M+115%

CapEx$729.0K+7,190%

Free cash flow$41.7M+111%

Valuation

See full

Market cap$605.65M-34.4%

P/E3.4×—

P/S1.5×-9.6×

Profitability

See full

Gross margin91.9%-3.5pp

Operating margin48.4%—

Net margin45.2%—

FCF margin48.7%+38.8pp

Returns & leverage

See full

Return on equity65.6%—

Debt / equity0×0.0×

Current ratio3×-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense.

The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's nontaxable or nondeductible items.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CorMedix's nontaxable or nondeductible items?: CorMedix (CRMD) reported nontaxable or nondeductible items of 0.4% in Q4 2025.
What does nontaxable or nondeductible items mean?: Measures the impact of non-deductible expenses on the company's effective tax rate as a percentage. It highlights how specific regulatory limitations on expense deductions influence the overall tax burden relative to statutory rates.